Company Filing History:
1 out of 832,891 Years Active: 2019
Title: Innovations in Alzheimer's Treatment by Te-Jen Lai
Introduction
Te-Jen Lai is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of medical research, particularly in the treatment of Alzheimer's disease. His innovative approach utilizes microRNAs as therapeutic agents, showcasing the potential of genetic engineering in medicine.
Latest Patents
Te-Jen Lai holds a patent for a composition and method of using miR-302 precursors as drugs for treating Alzheimer's disease. This invention relates to the use of recombinant microRNAs and their hairpin-like precursors as therapeutic drugs. Specifically, it focuses on the application of man-made miR-302 precursors for Alzheimer's therapy in humans. The invention outlines a method for expressing these precursors in prokaryotic cells, which can lead to advancements in regenerative medicine for various age-related degenerative diseases.
Career Highlights
Throughout his career, Te-Jen Lai has demonstrated a commitment to advancing medical science. His work on miR-302 precursors not only addresses Alzheimer's disease but also opens avenues for treating other conditions such as Parkinson's disease, osteoporosis, diabetes, and cancers. His innovative research has the potential to transform therapeutic strategies in regenerative medicine.
Collaborations
Te-Jen Lai has collaborated with notable colleagues, including Chih-Li Lin and Hsin-Hua Li. These partnerships have contributed to the development and refinement of his groundbreaking research.
Conclusion
Te-Jen Lai's contributions to the field of Alzheimer's treatment through his innovative use of microRNAs highlight the importance of genetic research in developing new therapies. His work exemplifies the potential for scientific advancements to improve health outcomes for aging populations.